Barkworth

Barkworth Updated 

Trend based FIB extension suggests a pull back to $2.88, while I consider $3 to be a very important, historical level. If SPY doesn't strike down, we'll see APHA charge batteries here, for another charge at key resistance.

Barkworth Updated 

Lots of selling pressure. I'm looking for a pull back to $12.

Barkworth Updated 

Lots of confluence on Jeffries' price target. Not unreasonable at all. 50% upside...

Barkworth Updated 

With a market cap of over $5B, Canopy Growth is still considered the market leader by many. However, current downsizing activity and write-offs confirm a smaller than anticipated international market, still no sight of profitability, and thus, continued cash burn. We may see the current triangle break upward, and test resistance once more, but I strongly believe...

Barkworth Updated 

The market leader by market cap. Earnings expected at the end of may, and estimates will have us expect another heavy loss. APHA surprised, however, and we can't ignore the fact that CGC too, reported an impressive increase of revenue with its most recent call. Still, I think that CGC, like CRON is a long term game. Volatility offers day and swing traders...

Barkworth

They expect their new shelf prospectus and reverse split to be completed on May 11. Based on last week's market cap, we would be looking at 35% dilution, but after yesterday's sell off, it is getting closer to 50%. I had a buy box for a bounce play, but for the time being, I will be avoiding ACB like the plague. ACB and CGC, they once were kings of a promised...

Barkworth Updated 

12 to 1 reverse split with a new shelf prospectus to immediately raise $200M. Current market cap $780M. That implies dilution of 25%, directly after splitting. Still, there are people buying at the current levels. Are those shorters, stocking up? I got APHA at recent lows. Earnings on Wednesday. I'm hoping for a killer. Then we'll leave ACB behind, forever.

Barkworth

I don't think drinks are where the money is. I also don't think CGC's footprint in the USA is all that impressive at the moment. The MSO's are making a killer with expansion and execution. CGC did manage to capture more market share in Canada, but looking at their revenue, cash burn, restructuring efforts, I think the market cap is still way too high to justify a...

Barkworth

Volatile as ever, the penny level only made it worse. Insane profits for those that understand how to day trade this asset. Respecting FIB levels as always, currently resting at the 0.5 of the most recent rally. What are we looking at? Bulls will need to work hard to aim for $1, while the bears will try and get her down to $0.59. Anybody noticed the buy signal on...

Barkworth Updated 

Broke bullish from a falling wedge. This was to be expected. Looks ready to attempt to get above MA50, this time with good underlying strength.

Barkworth Updated 

Looking very good. Respected FIB levels, set a daily higher low and lower high with clear pivot points. I'm currently looking for clues as to where it may be headed. I picked some up at $2.20, so I am in a very comfortable position, but I would like to add some. It may go lower from here, or it may try for the MA50. A close above MA50 would be a buy signal for me....

Barkworth

It tried to stay above MA20 for a few days, but I really think the ETF Alternative Harvest has been rebalancing their portfolio last week, which explains the sudden spike in volume for just a few selected asset, which are all in their portfolio. Don't misinterpret ACB's underlying weakness as "oversold". It is currently trading at fair value. It has fully...

Barkworth

Money gone. I have been following this company, curious to see how criminal activity plays out, but stayed on the sidelines as I don't like to gamble. I know many retail investors expected this to return to old highs with short term fix and a fresh license. In reality, if you invested, trading has now been halted on both the TSX and the NYSE, and you can't reach...

Barkworth Updated 

No idea what caused that insane volume, but it certainly doesn't look like anything sustainable. If you followed my earlier idea's, you know that my targets all hit. I don't know whereto from here, but since today's spike looks topped out, and we're headed into the weekend, perhaps we can try some FIB Retracement to see how it will drop back down. It worked with...

Barkworth

I don't know about you, but I absolutely love this chart. It hit my target as if it was my birthright, and is currently, carefully attempting a bounce. I'm not sure what is keeping her, and I do anticipate a touch of the lower yellow line, but Valens, like LABS, is a solid bet in these scary times. Short term, I am looking for a gap close, then, ultimately, a...

Barkworth

What's in store for Q4 earnings? I have no idea. I do know that I like LABS a lot. As with my other favourites, solid fundamentals and high growth potential. Fell right through my target - I ended up buying twice - and then bounced nicely. I am looking for a short term, sustained bounce towards $3.35 level, then gather some strength before moving higher again....

Barkworth Updated 

This company is still so young, it is hard to find levels of confluence and targets. I figured to just draw FIB chart from $0 to the top, to see how that would look, and it seems to provide more than just a few levels. I don't want to go out my way to analyse this asset before I'm certain that a bottom is in. Currently still trading below MA20, and I think it...

Barkworth Updated 

Another asset with excellent fundamentals, is Auxly Cannabis. I was just looking for levels of confluence. I think we will see XLY back at $0.70 soon, and longer term targets include $1.15 and $2. Earnings call coming up. We'll see where it takes us. I do believe we'll see XLY retest $0.29 before moving higher, but at the same time, it doesn't have to. This is...